III Department of Orthopedics, University of Bologna, Istituto Ortopedico Rizzoli, Via Pupilli, 1, 40136, Bologna, (BO), Italy.
Clin Orthop Relat Res. 2014 Jan;472(1):349-59. doi: 10.1007/s11999-013-3250-x. Epub 2013 Aug 24.
Surgical treatment of pelvic tumors with or without acetabular involvement is challenging. Primary goals of surgery include local control and maintenance of good quality of life, but the procedures are marked by significant perioperative morbidity and complications.
QUESTIONS/PURPOSES: We wished to (1) evaluate the frequency of infection after limb salvage surgical resection for bone tumors in the pelvis; (2) determine whether infection after these resections is associated with particular risk factors, including pelvic reconstruction, radiotherapy or chemotherapy, type of resection, and age; and (3) analyze treatment of these infections, particularly with respect to the need of additional surgery or hemipelvectomy.
From 1975 to 2010, 270 patients with pelvic bone tumors (149 with chondrosarcoma, 40 with Ewing's sarcoma, 27 with osteosarcoma, 18 with other primary malignant tumors, 11 with metastatic tumors, and 25 with primary benign tumors) were treated by surgical resection. Minimum followup was 1.1 years (mean, 8 years; range, 1-33 years). The resection involved the periacetabular area in 166 patients. In 137 patients reconstruction was performed; in 133 there was no reconstruction. Chart review ascertained the frequency of deep infections, how they were treated, and the frequency of resection arthroplasty or hemipelvectomies that occurred thereafter.
A total of 55 patients (20%) had a deep infection develop at a mean followup of 8 months. There were 20 infections in 133 patients without reconstruction (15%) and 35 infections in 137 patients with reconstruction (26 %). Survivorship rates of the index procedures using infection as the end point were 87%, 83%, and 80% at 1 month, 1 year, and 5 years, respectively. Infection was more common in patients who underwent pelvic reconstruction after resection (univariate analysis, p = 0.0326; multivariate analysis, p = 0.0418; odds ratio, 1.7718; 95% CI, 1.0243-3.0650); no other risk factors we evaluated were associated with an increased likelihood of infection. Despite surgical débridements and antibiotics, 16 patients (46%) had the implant removed and five (9%) underwent external hemipelvectomy (four owing to infection and one as a result of persistent infection and local recurrence).
Infection is a common complication of pelvic resection for bone tumors. Reconstruction after resection is associated with an increased risk of infection compared with resection alone, without significant difference in percentage between allograft and metallic prosthesis. When infection occurs, it requires removal of the implant in nearly half of the patients who have this complication develop, and external hemipelvectomy sometimes is needed to eradicate the infection.
骨盆肿瘤的手术治疗(包括髋臼受累或未受累)极具挑战性。手术的主要目标包括局部控制和维持良好的生活质量,但手术过程中围手术期发病率和并发症显著。
问题/目的:我们希望:(1)评估骨盆保肢手术后感染的发生率;(2)确定这些切除术后感染是否与特定的危险因素相关,包括骨盆重建、放疗或化疗、切除类型和年龄;(3)分析这些感染的治疗方法,特别是是否需要进一步手术或半骨盆切除术。
1975 年至 2010 年,270 名骨盆骨肿瘤患者(149 名软骨肉瘤、40 名尤文肉瘤、27 名骨肉瘤、18 名其他原发性恶性肿瘤、11 名转移性肿瘤和 25 名原发性良性肿瘤)接受了手术切除治疗。最低随访时间为 1.1 年(平均 8 年;范围 1-33 年)。166 名患者的髋臼周围区域被切除。137 名患者进行了重建,133 名患者未进行重建。图表回顾确定了深部感染的频率、治疗方法,以及随后发生的切除关节成形术或半骨盆切除术的频率。
共有 55 名患者(20%)在平均 8 个月的随访时发生深部感染。133 名未重建患者中有 20 例感染(15%),137 名重建患者中有 35 例感染(26%)。以感染为终点的指数手术的生存率分别为术后 1 个月、1 年和 5 年的 87%、83%和 80%。与单纯切除相比,切除后重建(单因素分析,p=0.0326;多因素分析,p=0.0418;比值比,1.7718;95%可信区间,1.0243-3.0650)的患者感染更常见;我们评估的其他任何风险因素均与感染的可能性增加无关。尽管进行了清创术和抗生素治疗,但仍有 16 名患者(46%)去除了植入物,5 名患者(9%)接受了外半骨盆切除术(4 名患者因感染,1 名患者因持续感染和局部复发)。
感染是骨盆骨肿瘤保肢切除术后的常见并发症。与单纯切除相比,切除后重建与感染风险增加相关,但同种异体移植物和金属假体之间的感染率没有显著差异。当感染发生时,近一半发生这种并发症的患者需要去除植入物,有时需要外半骨盆切除术以消除感染。